Patient and physician analytic goals for self-monitoring blood glucose instruments

Area of Science:

• Clinical Chemistry
• Diabetes Management
• Medical Device Technology

Background:

• Portable whole blood glucose meters are crucial for diabetes self-management.
• Determining acceptable analytical error is vital for ensuring meter accuracy and patient safety.
• Previous research has not fully elucidated the differing precision requirements between patients and healthcare providers.

Purpose of the Study:

• To establish the maximum allowable analytical error for portable whole blood glucose meters.
• To compare the acceptable blood glucose limits and precision requirements between diabetic patients and physicians.
• To inform the development and regulation of accurate and reliable glucose monitoring devices.

Main Methods:

• Interviews were conducted with 50 patients with diabetes (Type I and Type II) and 43 physicians (endocrinologists, family practitioners, general internists).
• Participants provided personal reference values for hypoglycemia, hyperglycemia, and acceptable blood glucose ranges.
• Allowable coefficients of variation (CV) were calculated based on these reference values.

Main Results:

• No significant differences in responses were found between Type I and Type II diabetic patients or among physician specialties.
• Physicians require higher precision at the hyperglycemia limit (7% CV) compared to patients (10% CV).
• Patients require higher precision around the lower acceptable glucose limit (8% CV) compared to physicians (14% CV).

Conclusions:

• Current portable glucose meters can meet the accuracy demands of both patients and physicians at normal and higher glucose concentrations.
• Manufacturers should prioritize optimal accuracy at 4.7 mmol/L (84.1 mg/dL) with a maximum CV of 7%.
• Understanding these differing precision needs can guide the design of more effective diabetes management tools.